27 December 2024

Results of 2023 Annual General Meeting (ASX Announcement)

Melbourne, Australia; 29 November 2023: Starpharma (ASX: SPL, OTCQX: SPHRY) announces the details of the resolutions and the proxies and votes received in respect of each resolution at its Annual General Meeting (AGM) held today in accordance with ASX Listing Rule 3.13.2 and section 251AA of the Corporations Act, as set out in the attached proxy and voting summary.

View/download the ASX Announcement: Results of 2023 Annual General Meeting.

This contains certain forward-looking statements.

Important Notice

This website is intended for people seeking information about Starpharma for investment and business purposes. This website contains information about products that may not be available, or approved, in all countries, or may be available under different trademarks, or for different indications. Individuals seeking information about a Starpharma product should visit the relevant product website in their country of residence or consult a healthcare provider. Nothing contained on this site should be considered a solicitation, promotion, or advertisement for any product, including those under development. Any information on this site is not intended to provide medical advice nor should be used as a substitute for the advice provided by a doctor or other healthcare provider.